Neuroprotection in Traumatic Brain Injury: Mesenchymal Stromal Cells can Potentially Overcome Some Limitations of Previous Clinical Trials

Traumatic brain injury (TBI) is a leading cause of death and disability worldwide. In the last 30 years several neuroprotective agents, attenuating the downstream molecular and cellular damaging events triggered by TBI, have been extensively studied. Even though many drugs have shown promising resul...

Descripción completa

Detalles Bibliográficos
Autores principales: Carbonara, Marco, Fossi, Francesca, Zoerle, Tommaso, Ortolano, Fabrizio, Moro, Federico, Pischiutta, Francesca, Zanier, Elisa R., Stocchetti, Nino
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2018
Materias:
Neurology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208094/
https://www.ncbi.nlm.nih.gov/pubmed/30405517
http://dx.doi.org/10.3389/fneur.2018.00885

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6208094/
https://www.ncbi.nlm.nih.gov/pubmed/30405517
http://dx.doi.org/10.3389/fneur.2018.00885

Ejemplares similares